Stages I-II/ Anal Cancer News

Share


Recent Stages I-II/ Anal Cancer News


3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (July 21, 2016)

Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

Amy Gibson Creates FIRST Cancer HairCARE Center for CancerConnect.com (July 19, 2016)

Amy Gibson Author | Emmy Nominated Soap Opera Star | Cancer Hair Loss Expert Leading Hair Loss Consultant Amy Gibson breaks new ground again, creating the Cancer HairCARE Center by Amy Gibson premiering... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (July 19, 2016)

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

Summer Camp Support Network for Children Affected by a Parent’s Cancer (July 18, 2016)

Camp Kesem at Syracuse University is a free, week-long summer camp for children affected by a parent’s cancer. Over 3 million children live with a parent with cancer, many more have lost a parent to... Continue Reading

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment (July 18, 2016)

The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... Continue Reading

Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations (July 14, 2016)

Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower women. Those who have the mutations... Continue Reading

Niraparib Improves Progression-Free Survival in Ovarian Cancer (July 13, 2016)

The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy. Each year in the United... Continue Reading

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (July 12, 2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting.... Continue Reading

Finding Balance: Scenes from a Family (July 11, 2016)

For many women, juggling professional success and family life presents challenges. Bringing home the skills that serve you in the workplace might just help you organize your life at home. By Sarah Shaw,... Continue Reading

Compliments: Accept the Gift with Grace (July 11, 2016)

By Denise King Gillingham, LMSW, ACC, CPM Why is it so hard to listen to nice things about yourself? It seems like it should be so easy—and enjoyable—but many of us react to compliments in ways that... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS